Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03349632 · ClinicalTrials.gov registry record · NA
Clinical Comparison of 4 Daily Disposable Soft Contact Lenses
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT03349632: Completed NA study, sponsored by Alcon Research.
NCT03349632 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03349632, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain on-eye performance data to inform contact lens product development and to further evaluate product performance in the intended population.
Primary Outcome
Overall quality of vision was collected binocularly and rated on a 10-point scale with 1 = poor to 10 = excellent. Subjects were asked "Thinking back over the last week, please rate our study lenses. Rate eyes together." No formal hypotheses was conducted; hence no inferential testing was performed.
Interventions
- DEVICE verofilcon A contact lenses
- DEVICE senofilcon A contact lenses
- DEVICE stenfilcon A contact lenses
- DEVICE etafilcon A contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2018-01-10 |
| Est. Completion | 2018-02-16 |
| Phase | NA |
What the finished NCT03349632 record still lists
NCT03349632 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which verofilcon A contact lenses is the first listed.
NCT03349632 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03349632 about?
NCT03349632 is a clinical study titled "Clinical Comparison of 4 Daily Disposable Soft Contact Lenses". The purpose of this study is to obtain on-eye performance data to inform contact lens product development and to further evaluate product performance in the intended population.
What is the current status of trial NCT03349632?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2018-01-10. Estimated completion is 2018-02-16.
What interventions are being tested in trial NCT03349632?
The interventions under investigation include: verofilcon A contact lenses (DEVICE), senofilcon A contact lenses (DEVICE), stenfilcon A contact lenses (DEVICE), etafilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT03349632?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03349632's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI